Find Faculty Members at MUSC.

Wenjian Gan PhD

Provider Image
  • Associate Professor
  • College of Medicine
  • Biochemistry and Molecular Biology
Academic Focus
  • Post-translational modifications in cell signaling pathways and cancer
Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit MyChart for medical appointments or to contact your provider.


Office Location


Education and Training

2012-2018    Postdoctoral Fellow, Beth Israel Deaconess Medical Center, Harvard Medical School

2007-2012    Ph.D.,  Peking University, Beijing, P.R. China.

2001-2005    B.S.,    Biotechnology, Guangxi University, Nanning, P.R. China.



A major research focus in my new laboratory is to investigate the roles of E3 ubiquitin ligases in cancer development, particularly the family of F-box E3 ubiquitin ligases. Specifically, I am interested in identifying the upstream regulators that modulate the activity of these E3 ubiquitin ligases, and characterizing their downstream substrates to dissect their functions in genome stability and tumorigenesis. I am also interested in identifying  deubiquitinases that antagonize these E3s’ roles. Another research focus in my laboratory is to study the aberrant activation of kinase cascades. I am interested in elucidating the molecular mechanisms underlying how post-translational modifications including phosphorylation and ubiquitination affect the activation of mTOR/Akt signaling pathway. Our goals are not only to expand our understanding the physiological roles of E3 ubiquitin ligases and mTOR/Akt signaling pathway, but also to develop novel strategies and drugs as potential therapeutic tools to target these deregulated signaling pathway for cancer therapies. To achieve these goals, we employ a range of complementary methods, including biochemistry, molecular and cellular biology, functional cell-based assays and mouse genetic models.